CIK 0001958777 · <br>Emerging growth company
FibroBiologics, Inc.
Sign in to watch- Ticker
- FBLG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863329066
- Phone
- 281-671-5150
- Business address
- 9350 KIRBY DRIVE, SUITE 300, HOUSTON, TX, 77054
- Former names
- FibroBiologics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Khoja Hamid Chief Scientific Officer | Grant or award | +298,508 | $1.68 | $500K | 301,571 |
| 2026-09-15 | Khoja Hamid Chief Scientific Officer | Grant or award · Warrant (Right to Buy) | +298,508 | 298,508 | ||
| 2026-06-23 | Hoffman Robert E. Director | Grant or award · Stock Option (Right to Buy) | +30,803 | 30,803 | ||
| 2026-06-23 | Cilento Richard C. Jr. Director | Grant or award · Stock Option (Right to Buy) | +30,803 | 30,803 | ||
| 2026-06-23 | Link Matthew Director | Grant or award · Stock Option (Right to Buy) | +30,803 | 30,803 | ||
| 2026-06-23 | Niklas Victoria Ninon Olivia Director | Grant or award · Stock Option (Right to Buy) | +30,803 | 30,803 | ||
| 2026-05-04 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +92,410 | 92,410 | ||
| 2026-05-04 | Khoja Hamid Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +61,607 | 61,607 | ||
| 2026-05-04 | Davis Jason Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +61,607 | 61,607 | ||
| 2026-05-04 | GARCIA RUBEN A General Counsel | Grant or award · Stock Option (Right to Buy) | +61,607 | 61,607 | ||
| 2026-03-04 | Khoja Hamid Chief Scientific Officer | Purchase | +30,000 | $0.38 | $11K | 61,250 |
| 2026-03-04 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | +15,872 | $0.38 | $6K | 5,958,147 |
| 2026-03-03 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | +18,200 | $0.41 | $7K | 5,942,275 |
| 2026-03-02 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Purchase | +17,428 | $0.35 | $6K | 5,924,075 |
| 2026-03-02 | Davis Jason Chief Financial Officer | Purchase | +70,000 | $0.41 | $29K | 70,000 |
| 2026-02-27 | GARCIA RUBEN A General Counsel | Purchase | +40,000 | $0.33 | $13K | 180,000 |
| 2025-12-11 | GARCIA RUBEN A General Counsel | Purchase | +140,000 | $0.34 | $48K | 140,000 |
| 2025-06-12 | Niklas Victoria Ninon Olivia Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-12 | Link Matthew Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-12 | Hoffman Robert E. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 1 of 2 · 40 trades